M&A Deal Summary |
|
|---|---|
| Date | 2002-10-07 |
| Target | Barton & Polansky Associates |
| Sector | Life Science |
| Buyer(s) | ICON |
| Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1990 |
| Sector | Life Science |
| Employees | 41,100 |
| Revenue | 8.1B USD (2023) |
ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The company specialises in the strategic development, management and analysis of programs that support clinical development – from compound selection to Phase I-IV clinical studies. ICON was founded in 1990 and is based in Dublin, Ireland.
| DEAL STATS | # |
|---|---|
| Overall | 5 of 29 |
| Sector (Life Science) | 3 of 16 |
| Type (Add-on Acquisition) | 5 of 25 |
| State (New York) | 3 of 4 |
| Country (United States) | 4 of 18 |
| Year (2002) | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2002-10-07 |
Managed Clinical Solutions
New York, New York, United States Managed Clinical Solutions, Inc. is a provider of contract staffing solutions to the pharmaceutical research industry. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2003-01-24 |
Medeval Group
United Kingdom Medeval Group Ltd. is a UK clinical pharmacology group providing Phase I and bioanalytical services to the pharmaceutical and biotechnology industries. Medeval is a specialist provider of Phase I clinical trials, with a strong bias toward the execution of “First-in-man” studies. |
Buy | $16M |
